The greater the odds of partnership or buyout. Why? Do somee dd. Companies who usually receive good news from FDA are anxious to play it to the max. Insmed has opted to say little to nothing. A clear indication that major news is not far away. There are probably 2 or 3 major pharmas in the picture. We should know someting concrete fairly soon. The next quarterly cc is just around the corner.
Dorian (breaking "radio silence"), the fact that not ONE analyst has spoken up (JMP has not said one thing) since the BT was announced says there has to be something brewing. Also, they have not announced a CMO appointment/hiring. Been almost 4 months since Dr Gupta was reassigned (4/2/14). They should have met with the FDA and EMA by now.